JaimeGerardoDevilleMD

Pediatric Infectious Disease • Los Angeles, CA

HIV/AIDS Pediatrics, Pediatric Infections Associated with Transplant/Immunocompromised States

Professor, Pediatrics, UCLA School of Medicine

Join to view full profile

Dr. Deville is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Deville's full profile

Already have an account?

Office
10833 Le Conte Ave
# 12-441
Los Angeles, CA 90095
Phone+1 310-206-3952

Fax+1 310-206-0209

Education & Training

Los Angeles County-Harbor-UCLA Medical CenterFellowship, Pediatric Infectious Diseases, 1993 - 1996
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 1988 - 1992
Cayetano Heredia UniversityClass of 1985

Certifications & Licensure

CA State Medical License 1992 - 2026
NC State Medical License 1987 - 1999
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents Start of enrollment: 2010 Oct 08
Completed
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Start of enrollment: 2011 Nov 01
Completed
Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT) Start of enrollment: 2012 Feb 01
Active, not recruiting
Not Applicable
Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions Start of enrollment: 2020 Aug 01
Not yet recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032.
Kristina M Brooks, Kristin Baltrusaitis, Diana F Clarke, Sharon Nachman, Jennifer Jao
The Journal of Infectious Diseases. 2024-10-16
1 citations
Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
Amina Ahmed, Flor M Munoz, William J Muller, Allison Agwu, David W Kimberlin
Pediatrics. 2024-03-01
1 citations
Academic Health Centers and Humanitarian Crises: One Health System's Response to Unaccompanied Children at the Border.
Sherin U Devaskar, Coleen K Cunningham, Robin H Steinhorn, Cynthia Haq, Johnese Spisso
Academic Medicine. 2023-03-01

Press Mentions

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)December 9th, 2024
Should My Teen Get a COVID-19 Booster? Experts DiscussJanuary 6th, 2022
Miller Children’s Hospital Celebrates 20 Years of Zero Mother-Baby HIV TransmissionsNovember 23rd, 2015

Grant Support

A Phase I/II, Multicenter, Open-Label, Noncomparative AIDS Clincal TrialsNational Center For Research Resources2010

Other Languages

Spanish